Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution".
作者信息
Lebwohl Mark, Rivera-Oyola Ryan, Murrell Dedee F
机构信息
Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mt Sinai Hospital, New York, New York.
Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mt Sinai Hospital, New York, New York.
出版信息
J Am Acad Dermatol. 2020 Jun;82(6):e215. doi: 10.1016/j.jaad.2020.03.103. Epub 2020 Apr 10.
Abstract
摘要
相似文献
1
Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution".回复：“2019冠状病毒病、梅毒与银屑病和银屑病关节炎的生物疗法：一则警示”
J Am Acad Dermatol. 2020 Jun;82(6):e215. doi: 10.1016/j.jaad.2020.03.103. Epub 2020 Apr 10.
2
COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.新型冠状病毒肺炎、梅毒与银屑病及银屑病关节炎的生物治疗：一则警示
J Am Acad Dermatol. 2020 Jun;82(6):e213. doi: 10.1016/j.jaad.2020.03.079. Epub 2020 Apr 1.
3
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
4
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.在新冠疫情期间，银屑病的生物治疗并非一种选择。
J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6.
5
Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.2019冠状病毒病疫情期间银屑病的生物治疗：选择需权衡风险与获益。
Dermatol Ther. 2020 Jul;33(4):e13490. doi: 10.1111/dth.13490. Epub 2020 May 20.
6
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.免疫介导性炎症疾病中的新冠病毒病——来自纽约的病例系列
N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29.
7
COVID-19 era: A chance to learn something new about monitoring psoriatic patients in biological therapy.新冠疫情时代：一个了解生物治疗中银屑病患者监测新情况的机会。
Dermatol Ther. 2020 Jul;33(4):e13805. doi: 10.1111/dth.13805. Epub 2020 Jul 13.
8
Reply: "Biologics for psoriasis during COVID-19 outbreak".回复：“新冠疫情期间用于银屑病的生物制剂”
J Am Acad Dermatol. 2020 Jun;82(6):e217-e218. doi: 10.1016/j.jaad.2020.04.004. Epub 2020 Apr 10.
9
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre.对评论的回复：炎症性肠病患者生物治疗前新冠病毒感染的筛查：首要原则是不伤害。 （注：“primum non nŏcēre”是拉丁语，意为“首要原则是不伤害” ）
Dig Liver Dis. 2020 Nov;52(11):1248-1249. doi: 10.1016/j.dld.2020.07.021. Epub 2020 Jul 27.
10
Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.一名患有银屑病和银屑病关节炎的患者在使用阿达木单抗治疗期间COVID-19感染的非复杂病程。
Dermatol Ther. 2020 Jul;33(4):e13708. doi: 10.1111/dth.13708. Epub 2020 Jun 26.
引用本文的文献
1
Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?2019年冠状病毒病大流行对慢性炎症性免疫介导性皮肤病病程及管理的影响：有哪些证据？
Clin Dermatol. 2021 Jan-Feb;39(1):52-55. doi: 10.1016/j.clindermatol.2020.12.012. Epub 2020 Dec 15.
2
Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient.一名银屑病患者注射古塞库单抗后新冠病毒症状改善。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e363-e364. doi: 10.1111/jdv.16590. Epub 2020 Jun 4.
本文引用的文献
1
COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.新型冠状病毒肺炎、梅毒与银屑病及银屑病关节炎的生物治疗：一则警示
J Am Acad Dermatol. 2020 Jun;82(6):e213. doi: 10.1016/j.jaad.2020.03.079. Epub 2020 Apr 1.
2
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
3
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.新型冠状病毒（COVI-19 或 SARS-CoV-2）诱导促炎细胞因子（IL-1 和 IL-6）和肺部炎症：抗炎策略。
J Biol Regul Homeost Agents. 2020;34(2):327-331. doi: 10.23812/CONTI-E.
4
Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.人类白细胞介素 17 免疫的先天缺陷是慢性黏膜皮肤念珠菌病的基础。
Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616-22. doi: 10.1097/ACI.0b013e328358cc0b.
5
Mendelian susceptibility to mycobacterial infection in man.人类对分枝杆菌感染的孟德尔易感性。
Curr Opin Immunol. 1998 Aug;10(4):413-7. doi: 10.1016/s0952-7915(98)80114-3.
Zotero 插件